These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 6630594)
1. Pemoline, depressive symptoms, and escape from dexamethasone suppression. Farmer P; Unis AS; Hsu G J Clin Psychopharmacol; 1983 Oct; 3(5):331-2. PubMed ID: 6630594 [No Abstract] [Full Text] [Related]
2. Depression following pemoline withdrawal in a hyperactive child. Brown RT; Borden KA; Spunt AL; Medenis R Clin Pediatr (Phila); 1985 Mar; 24(3):174. PubMed ID: 3971647 [No Abstract] [Full Text] [Related]
3. Change from Mg-pemoline to bupropion in a 12-year-old boy with attention-deficit hyperactivity disorder. Bloomingdale LM J Clin Psychopharmacol; 1990 Oct; 10(5):382-3. PubMed ID: 2124222 [No Abstract] [Full Text] [Related]
4. Pemoline-induced Tourette's disorder: a case report. Bachman DS Am J Psychiatry; 1981 Aug; 138(8):1116-7. PubMed ID: 6942661 [TBL] [Abstract][Full Text] [Related]
5. Pemoline in adult attention deficit hyperactivity disorder: predictors of nonresponse. Heiligenstein E; Anders J J Am Coll Health; 1997 Mar; 45(5):225-9. PubMed ID: 9069682 [TBL] [Abstract][Full Text] [Related]
6. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. Bostic JQ; Biederman J; Spencer TJ; Wilens TE; Prince JB; Monuteaux MC; Sienna M; Polisner DA; Hatch M J Child Adolesc Psychopharmacol; 2000; 10(3):205-16. PubMed ID: 11052410 [TBL] [Abstract][Full Text] [Related]
7. Effect on growth in pemoline-treated children with attention deficit disorder. Friedmann N; Thomas J; Carr R; Elders J; Ringdahl I; Roche A Am J Dis Child; 1981 Apr; 135(4):329-32. PubMed ID: 7211792 [TBL] [Abstract][Full Text] [Related]